Psychology Today

In the U.S. and other developed countries, there are now clear signs that child and adolescent mental disorders are overdiagnosed.

The expanding influence of genomics on our lives.

On rereading “The Authoritarian Personality” in 2017.

In the battle against opioid addiction, court-released documents show drug makers deliberately blocked efforts to curb prescribing.

Selective reporting and inflated effect sizes mar even high-impact studies in the neurosciences, according to two weighty new analyses.

A stress on anticipated harmony and positivity is part of the problem.

According to two new studies, outcome switching in clinical trials is widespread.

Almost half the country reports significant, recurring discrimination tied to race and ethnicity.

On the "ethical perils" facing a branch of medicine now greatly beholden to its industry sponsors.

Neuropolitics is going global. To what end? At what cost?

Ghostwriters, massaged data, tiny print, and children’s toys—part of Big Pharma's arsenal of "defeat devices," outlined in Steven Brill's series, America's Most Admired Lawbreaker.

Diagnoses of ADHD in school-age children jump 42 percent and the figures overall may be worse.

Will the FDA succumb to lobbyists accusing it of gender bias?

Newspaper of record criticized for its tardy response to overmedicalization.